Stay updated with breaking news from Lantern Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lantern Pharma Inc. , a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence and machine learning platform to transform the cost, pace, and timeline of... | March 28, 2023
EF Hutton Acquisition Co. I reaffirmed their buy rating on shares of Lantern Pharma (NASDAQ:LTRN – Get Rating) in a report issued on Tuesday morning, Benzinga reports. The firm currently has a $11.00 price target on the stock. Lantern Pharma Price Performance Shares of Lantern Pharma stock opened at $4.52 on Tuesday. Lantern Pharma has […]
DALLAS--(BUSINESS WIRE)--Feb 27, 2023--
Presented by D CEO and Dallas Innovates, program honorees included David C. Williams of AT&T, Andrew Bender of DZS, Celanese Corp, Hedera and Swirlds, and more.
Panna Sharma: Thank you, Nicole. Good afternoon, everyone. And welcome to our third quarter 2022 earnings call.